The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells

Kerl, Kornelius; Ries, David; Unland, Rebecca; Borchert, Christiane; Moreno, Natalia; Hasselblatt, Martin; Jürgens, Heribert; Kool, Marcel; Görlich, Dennis; Eveslage, Maria; Jung, Manfred; Meisterernst, Michael; Frühwald, Michael

doi:10.1186/1471-2407-13-286

BMC Cancer

Article metrics
Last updated: Sun, 28 Apr 2024 10:15:59 Z

The histone deacetylase inhibitor SAHA acts in synergism with fenretinide and doxorubicin to control growth of rhabdoid tumor cells

Access & Citations

5685

Article Accesses
38

Web of Science
36

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com